http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104383578-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
filingDate 2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104383578-B
titleOfInvention A kind of graphene oxide graft modification regenerated oxycellulose as styptic material and preparation method thereof
abstract A kind of graphene oxide graft modification regenerated oxycellulose as styptic material and preparation method thereof, it relates to a kind of hemostatic material and preparation method thereof. The object of the invention is to solve existing oxidized regenerated cellulose material modified exist the mechanical strength of material and bio-absorbable poor, anthemorrhagic performance promotes the little problem of amplitude. Prepared by the graphene oxide that a kind of graphene oxide graft modification regenerated oxycellulose as styptic material contains amino group by surface and oxidized regenerated cellulose; Preparation method: one, the graphene oxide of preparation chloride; Two, the graphene oxide that preparation contains amino group; Three, chemical graft, obtains graphene oxide graft modification regenerated oxycellulose as styptic material. The graphene oxide graft modification regenerated oxycellulose as styptic material that uses the present invention to prepare stops blooding, and bleeding stopping period has reduced by 7%~17%. The present invention can obtain a kind of graphene oxide graft modification regenerated oxycellulose as styptic material and preparation method thereof.
priorityDate 2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453447712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428

Total number of triples: 34.